(Q36481536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Andrew M Evens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

S Trifilio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Singhal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Tallman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Rashid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Fishman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Masino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Pi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Mehta

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

997-1001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16708061%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705379

21 January 2020

exact match

0 references

cites work

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Urate oxidase: primary structure and evolutionary implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Treatment of impending tumor lysis with single-dose rasburicase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

The price tag on progress--chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

inferred from DOI database lookup

7 January 2021

based on heuristic

Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379

inferred from DOI database lookup

7 January 2021

based on heuristic

Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705379